Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT01926041
NA

The Effectiveness of Smoking Cessation in Prediabetic Smokers

Sponsor: National Taiwan University Hospital

View on ClinicalTrials.gov

Summary

Existing literature investigating the impact of smoking cessation on new-onset diabetes mellitus (DM) risk is conflicting. Combing the need for smoking cessation and body weight self-management to prevent the progression of prediabetes stage into DM, with the public implementation of the second-generation cessation program, we aimed to study the effectiveness of the Fight Tobacco and Stay Fit (FIT2) program aiming at promoting smoking cessation and restricting post-cessation weight gain (PCWG) together in prediabetic smokers regarding long-term glycemic and DM-related health outcomes.

Key Details

Gender

All

Age Range

30 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

589

Start Date

2013-08-01

Completion Date

2027-12-31

Last Updated

2025-06-24

Healthy Volunteers

No

Interventions

DRUG

Varenicline for tobacco smoking cessation

The 16-week varenicline course conforms to real-practice government regulations in Taiwan.

BEHAVIORAL

Individualized counseling about both smoking cessation and weight control techniques

The FIT2 program also offers behavior coaching in diet and physical activity to restrict post-cessation weight gain, which is not covered in conventional smoking cessation services.

Locations (1)

National Taiwan University Hospital and its Yunlin branch

Taipei, Department of Family Medicine, Taiwan